These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36757979)

  • 1. Outcomes of vaccinations against respiratory diseases in patients with end-stage renal disease undergoing hemodialysis: A systematic review and meta-analysis.
    Puspitasari M; Sattwika PD; Rahari DS; Wijaya W; Hidayat ARP; Kertia N; Purwanto B; Thobari JA
    PLoS One; 2023; 18(2):e0281160. PubMed ID: 36757979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review of the efficacy and safety of intradermal versus intramuscular hepatitis B vaccination in end-stage renal disease population unresponsive to primary vaccination series.
    Yousaf F; Gandham S; Galler M; Spinowitz B; Charytan C
    Ren Fail; 2015 Aug; 37(7):1080-8. PubMed ID: 26258528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of COVID-19 Vaccination in Patients With End-Stage Renal Disease Undergoing Maintenance Hemodialysis: The Efficacy of a Mix-and-Match Strategy.
    Park JS; Minn D; Hong S; Jeong S; Kim S; Lee CH; Kim B
    J Korean Med Sci; 2022 Jun; 37(23):e180. PubMed ID: 35698835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and Safety of Reduced-Dose Intradermal vs Intramuscular Influenza Vaccines: A Systematic Review and Meta-analysis.
    Egunsola O; Clement F; Taplin J; Mastikhina L; Li JW; Lorenzetti DL; Dowsett LE; Noseworthy T
    JAMA Netw Open; 2021 Feb; 4(2):e2035693. PubMed ID: 33560425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and safety of SARS-CoV-2 vaccine in hemodialysis patients: A systematic review and meta-analysis.
    Peiyao R; Mengjie Y; Xiaogang S; Wenfang H; Danna Z; Yuqun Z; Juan J; Qiang H
    Front Public Health; 2022; 10():951096. PubMed ID: 36211647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors affecting seroconversion after influenza A/H1N1 vaccination in hemodialysis patients.
    Moon SJ; Lee SH; Byun YH; Yun GY; Kim SK; Seong BL; Kim AR; Sun Park E; Kim HJ; Lee JE; Ha SK; Lee JM; Park HC
    BMC Nephrol; 2012 Dec; 13():165. PubMed ID: 23206898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological response to influenza A H1N1 vaccine (Pandemrix®) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients.
    Ott U; Sauerbrei A; Lange J; Schäfler A; Walther M; Wolf G; Wutzler P; Zell R; Krumbholz A
    Med Microbiol Immunol; 2012 Aug; 201(3):297-302. PubMed ID: 22350187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and Safety of Influenza Vaccination in Systemic Lupus Erythematosus Patients Compared with Healthy Controls: A Meta-Analysis.
    Liao Z; Tang H; Xu X; Liang Y; Xiong Y; Ni J
    PLoS One; 2016; 11(2):e0147856. PubMed ID: 26845680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroresponse to Inactivated and Recombinant Influenza Vaccines Among Maintenance Hemodialysis Patients.
    Manley HJ; Lacson EK; Aweh G; Chen Li N; Weiner DE; Miskulin DC; Hsu CM; Kapoian T; Hayney MS; Meyer KB; Johnson DS
    Am J Kidney Dis; 2022 Sep; 80(3):309-318. PubMed ID: 35288216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Adolescents, Children, and Infants: A Systematic Review and Meta-Analysis.
    Du Y; Chen L; Shi Y
    Front Public Health; 2022; 10():829176. PubMed ID: 35493393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Probiotics and Prebiotics on Immune Response to Influenza Vaccination in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Lei WT; Shih PC; Liu SJ; Lin CY; Yeh TL
    Nutrients; 2017 Oct; 9(11):. PubMed ID: 29077061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the efficacy, safety and influencing factors of concomitant and sequential administration of viral respiratory infectious disease vaccines: a systematic review and meta-analysis.
    Lu D; Han Y; Xu R; Qin M; Shi J; Zhang C; Zhang J; Ye F; Luo Z; Wang Y; Wang C; Wang C
    Front Immunol; 2023; 14():1259399. PubMed ID: 38179050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients.
    Lertdumrongluk P; Changsirikulchai S; Limkunakul C; Prachukthum P; Punpiput P; Buppanharun R; Chotpitayasunondh C
    Vaccine; 2012 Feb; 30(6):1108-14. PubMed ID: 22178515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients.
    Chang YT; Guo CY; Tsai MS; Cheng YY; Lin MT; Chen CH; Shen D; Wang JR; Sung JM
    Vaccine; 2012 Jul; 30(33):5009-18. PubMed ID: 22658967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults.
    Xu K; Wang Z; Qin M; Gao Y; Luo N; Xie W; Zou Y; Wang J; Ma X
    Front Immunol; 2023; 14():1113156. PubMed ID: 36936964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to influenza vaccination in ESRD patients undergoing hemodialysis vs. hemodiafiltration.
    Nongnuch A; Ngampongpan W; Srichatrapimuk S; Wongsa A; Thongpraphai S; Boonarkart C; Sanmeema N; Chittaganpitch M; Auewarakul P; Tassaneetrithep B; Davenport A; Phuphuakrat A
    PLoS One; 2020; 15(2):e0227719. PubMed ID: 32012159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza vaccination in patients with end-stage renal disease: systematic review and assessment of quality of evidence related to vaccine efficacy, effectiveness, and safety.
    Remschmidt C; Wichmann O; Harder T
    BMC Med; 2014 Dec; 12():244. PubMed ID: 25523432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High seroprotection rates and geometric mean titre increases after repeated annual influenza vaccinations in a cohort of HIV-infected adults in Austria.
    Kitchen M; Leierer G; Kistner O; Wodal W; Gisinger M; Zangerle R; Sarcletti M
    Vaccine; 2022 Jun; 40(29):3948-3953. PubMed ID: 35606234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvanted-influenza vaccination in patients infected with HIV: a systematic review and meta-analysis of immunogenicity and safety.
    Chen YC; Zhou JH; Tian JM; Li BH; Liu LH; Wei K
    Hum Vaccin Immunother; 2020 Mar; 16(3):612-622. PubMed ID: 31567058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.